CT26-hNECTIN4

PDF 받기

Strain Information

검증 데이터

image.png

Fig1. NECTIN4 expression expression in CT26-hNECTIN4 cell lines.

image.png

Fig2. In vivo validation of CT26-hNECTIN4 in BALB/c mice. 

BALB/c mice were inoculated with CT26-hNECTIN4 subcutaneously at 3×106 cells/mouse inoculum for tumor development.

image.png

Fig3. NECTIN4 expression in tumors after in vivo growth of CT26-hNECTIN4 in wild type BALB/c mice.

image.png

Fig4. NECTIN4 expression in tumors after in vivo growth of CT26-hNECTIN4 in wild type BALB/c mice.


Related Strain(s)

당신은 또한 좋아할 수 있습니다

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

조회
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

조회